Is Tesamorelin Legal in New York?

AFDA Approved
FDA ApprovedPrescription RequiredWADA Banned
New York: Restrictive

New York has a restrictive regulatory stance on peptides. Compounding of non-approved peptides is restricted by state regulations. Age restrictions apply for certain peptide therapies.

Tesamorelin Availability in New York

Available by Prescription

As an FDA-approved medication (approved for Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy), Tesamorelin is available by prescription in New York and all other U.S. states. Contact a licensed healthcare provider to discuss whether Tesamorelin is appropriate for your situation. Brand names include: Egrifta, Egrifta SV.

Key Facts

PeptideTesamorelin
StateNew York
FDA StatusApproved (Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy)
Evidence LevelLevel A
State StanceRestrictive
Compounding AllowedNo
Age RestrictionsYes
Prescription RequiredYes
WADA BannedYes
Controlled SubstanceNo

Tesamorelin in New York: FAQ

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.

Tesamorelin Legal Status in Other States